Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 30, 2013
[Evaluation of non-surgical therapy as a treatment option for patients with colorectal cancer]Yuichiro Yano, Yutaro Kubota, Yasutsuna Sasaki
Cureus|December 27, 2024
Severe Polymyalgia Rheumatica-Like Syndrome Induced by Immune Checkpoint Inhibitor: A Case Report and Literature ReviewToshiaki Tsurui, Hirotsugu Ariizumi, Yutaro Kubota, et al.
World Journal of Gastroenterology|November 26, 2015
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancerKen-ichi Fujita, Yutaro Kubota, Hiroo Ishida, et al.
Current Drug Metabolism|January 7, 2017
Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management with Clinical PharmacologyKen-Ichi Fujita, Hiroo Ishida, Yutaro Kubota, et al.
World Journal of Gastrointestinal Oncology|March 1, 2024
Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case reportToshiaki Tsurui, Yuya Hirasawa, Yutaro Kubota, et al.
In Vivo (Athens, Greece)|April 30, 2024
Methionine Dependence of Hair Maintenance in C57BL/6 MiceYutaro Kubota, Nundini Varshney, Keita Kobayashi, et al.
In Vivo (Athens, Greece)|August 31, 2023
Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment AloneYutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Cancer Chemotherapy and Pharmacology|March 8, 2024
Association of VEGFA and CCL4L2 polymorphisms with hand-foot skin reaction and survival of regorafenib in Japanese patients with colorectal cancerKoutaro Ono, Remi Murase, Natsumi Matsumoto, et al.
In Vivo (Athens, Greece)|October 29, 2022
Chloroquine Combined With Rapamycin Arrests Tumor Growth in a Patient-derived Orthotopic Xenograft (PDOX) Mouse Model of Dedifferentiated LiposarcomaNoriyuki Masaki, Yusuke Aoki, Yutaro Kubota, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2025
Association of IL12RB2, RORC, and class II HLA polymorphisms with severe erythema multiforme of regorafenib in Japanese patients with colorectal cancerGeonwoo Lee, Remi Murase, Natsumi Matsumoto, et al.
Pageof 13